Feedback / Questions
ISM5059 - Insilico Medicine
https://www.prnewswire.com/news-releases/insilico-medicine-nominates-ism5059-the-peripheral-restricted-nlrp3-inhibitor-as-preclinical-candidate-for-the-treatment-of-multiple-inflammatory-and-metabolism-indications-302679925.html
Feb 5, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next